(Aryloxy)alkyl alicyclic amines as 5-HT7 receptor inverse agonists and their use
PL452052A1Pending Publication Date: 2026-11-16JAGIELLONIAN UNIVERSITY +2
0 Cites 0 Cited by
Patent Information
- Application Number
- PL2025452052
- Authority / Receiving Office
- PL · PL
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-15
- Publication Date
- 2026-11-16
Abstract
The application discloses (aryloxy)alkyl derivatives of alicyclic amines defined by general formula (I) as compounds having the characteristics of selective and metabolically stable 5-HT7 receptor inverse agonists. The application also relates to the use of these compounds or pharmaceutically acceptable salts thereof for the preparation of a medicament for the treatment of disorders such as depression, anxiety disorders, panic disorder, obsessive-compulsive disorder, attention deficit hyperactivity disorder, autism spectrum disorder, schizophrenia, the treatment of diseases associated with neurodegeneration, pain, irritable bowel syndrome, and pharmaceutical compositions containing these compounds.
Need to check novelty before this filing date? Find Prior Art
